Lysine and arginine reduce the effects of cerebral ischemic insults and inhibit glutamate-induced neuronal activity in rats

Frontiers in Integrative Neuroscience

Volumn , Issue JUNE 2010, 2010, Pages 1-10

  Kondoh, Takashi ^a,b   Kameishi, Makiko ^a   Mallick, Hruda Nanda ^c   Ono, Taketoshi ^d   Torii, Kunio ^a  

^a AJINOMOTO CO INC   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Arginine; Cerebral edema; Glutamate receptor; Ischemia; Lysine; Magnetic resonance imaging; Microiontophoretic application; Middle cerebral artery occlusion

Indexed keywords

ARGININE; GLUTAMIC ACID; LYSINE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DOSE COMPARISON; DRUG MEGADOSE; IN VIVO STUDY; INTRACRANIAL PRESSURE; LOW DRUG DOSE; MALE; MICROIONTOPHORESIS; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE MEMBRANE; NEUROIMAGING; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; ZONA INCERTA;

EID: 78650304376     PISSN: 16625145     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnint.2010.00018     Document Type: Article

References (51)

1. Bederson, J. B., Pitts, L. H., Germano, S. M., Nishimura, M. C., Davis, R. L., and Bartkowski, H. M. (1986). Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantifca-tion of experimental cerebral infarction in rats. Stroke 17, 1304-1308.
2. Belayev, L., Alonso, O. F., Busto, R., Zhao, W., and Ginsberg, M. D. (1996). Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 27, 1616-1623.
3. Borlongan, C. V., Yamamoto, M., Takei, N., Kumazaki, M., Ungsuparkorn, C., Hida, H., Sanberg, P. R., and Nishino, H. (2000). Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia. FASEB J. 14, 1307-1317.
4. Bronstein, D. M., Perez-Otano, I., Sun, V., Mullis Sawin, S. B., Chan, J., Wu, G. C., Hudson, P. M., Kong, L. Y., Hong, J. S., and McMillian, M. K. (1995). Glia-dependent neurotoxicity and neuro-protection in mesencephalic cultures. Brain Res. 704, 112-116.
5. Buisson, A., Plotkine, M., and Boulu, R. G. (1992). The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal ischaemia. Br. J. Pharmacol. 106, 766-767.
6. Caramia, F., Yoshida, T., Hamberg, L. M., Huang, Z., Hunter, G., Wanke, I., Zaharchuk, G., Moskowitz, M. A., and Rosen, B. R. (1998). Measurement of changes in cerebral blood volume in spontaneously hypertensive rats following l-arginine infusion using dynamic susceptibility contrast MRI. Magn. Reson. Med. 39, 160-163.
7. Chang, Y. F., and Gao, X. M. (1995). l-lysine is a barbiturate-like anticonvulsant and modulator of the benzodiazepine receptor. Neurochem. Res. 20, 931-937.
8. 2+-sensing receptor. Proc. Natl. Acad. Sci. USA 97, 4814-4819.
9. Curtis, D. R., and Koizumi, K. (1961). Chemical transmitter substances in brain stem of cat. J. Neurophysiol. 24, 80-90.
10. Dalkara, T., Morikawa, E., Panahian, N., and Moskowitz, M. A. (1994). Blood fow-dependent functional recovery in a rat model of focal cerebral ischemia. Am. J. Physiol. 267, H678-H683.
11. Datta, D., Kundu, P. K., Biswas, S., Dasgupta, S., Bhinge, A., and Chandran, V. (2000). Effect of cationic amino acid, l-lysine and its polymers on the growth and secretion of hybri-doma cell line OKT-3. Hybridoma 19, 339-346.
12. Ebenezar, K. K., Sathish, V., and Devaki, T. (2003). Effect of l-arginine and l-lysine on lysosomal hydrolases and membrane bound phosphatases in experimentally induced myocardial infarction in rats. Mol. Cell Biochem. 247, 163-169.
13. Egan, J. M., Henderson, T. E., and Bernier, M. (1995). Arginine enhances glyco-gen synthesis in response to insulin in 3T3-L1 adipocytes. Am. J. Physiol. 269, E61-E66.
14. Halliwell, B., Gutteridge, J. M. C., and Cross, C. E. (1992). Free radicals, antioxidants, and human disease: Where we are now? J. Lab. Clin. Med. 119, 598-620.
15. Hatashita, S., Hoff, J. T., and Salamat, S. M. (1988). Ischemic brain edema and the osmotic gradient between blood and brain. J. Cereb. Blood Flow Metab. 8, 552-559.
16. Johnson, J. L. (1978). The excitant amino acids glutamic and aspartic acid as transmitter candidates in the vertebrate central nervous system. Prog. Neurobiol. 10, 155-202.
17. Kato, T., Sano, M., and Mizutani, N. (1987). Inhibitory effect of intravenous lysine infusion on urea cycle metabolism. Eur. J. Pediatr. 146, 56-58.
18. Kondoh, T., Uneyama, H., Nishino, H., and Torii, K. (2002). Melatonin reduces cerebral edema formation caused by transient forebrain ischemia in rats. Life Sci. 72, 583-590.
19. Kozniewska, E., Roberts, T. P. L., Tsuura, M., Mintorovitch, J., Moseley, M. E., and Kucharczyk, J. (1995). NG-nitro-l-arginine delays the development of brain injury during focal ischemia in rats. Stroke 26, 282-289.
20. Kuluz, J. W., Prado, R. J., Dietrich, W. D., Schleien, C. L., and Watson, B. D. (1993). The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats. Stroke 24, 2023-2029.
21. Lewén, A., Matz, P., and Chan, P. H. (2000). Free radical pathways in CNS injury. J. Neurotrauma 17, 871-890.
22. Lipton, S. A., Choi, Y. B., Pan, Z. H., Lei, S. Z., Chen, H. S., Sucher, N. J., Loscalzo, J., Singel, D. J., and Stamler, J. S. (1993). A redox-based mechanism for the neuroprotective and neurode-structive effects of nitric oxide and related nitrosocompounds. Nature 364, 626-632.
23. 2+ of NMDA responses in spinal cord neurones. Nature 309, 261-263.
24. Morikawa, E., Rosenblatt, S., and Moskowitz, M. A. (1992). l-Arginine dilates rat pial arterioles by nitric oxide-dependent mechanisms and increases blood flow during focal cerebral ischaemia. Br. J. Pharmacol. 107, 905-907.
25. Morikawa, E., Moskowitz, M. A., Huang, Z., Yoshida, T., Irikura, K., and Dalkara, T. (1994). l-Arginine infusion promotes nitric oxide-dependent vasodilation, increases rCBF and reduces infarction volume in the rat. Stroke 25, 429-435.
26. Nishimura, F., Nishihara, M., Mori, M., Torii, K., and Takahashi, M. (1995). Excitability of neurons in the ventro-medial nucleus in rat hypothalamic slices: modulation by amino acids at cerebrospinal fuid levels. Brain Res. 691, 217-222.
27. Nowak, L., Bregestovski, P., Ascher, P., Herbert, A., and Prochiantz, A. (1984). Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307, 462-465.
28. Oldendorf, W. H., and Szabo, J. (1976). Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am. J. Physiol. 230, 94-98.
29. Paxinos, G., and Watson, C. (1997). The Rat Brain in Stereotaxic Coordinates, Compact, 3rd Edn. San Diego: Academic Press.
30. Quast, M. J., Wei, J., and Huang, N. C. (1995). Nitric oxide synthase inhibitor NG-nitro-l-arginine methyl ester decreases ischemic damage in reversible focal cerebral ischemia in hyperg-lycemic rats. Brain Res. 677, 204-212.
31. Ridet, J. L., Malhotra, S. K., Privat, A., and Gage, F. H. (1997). Reactive astro-cytes: cellular and molecular cues to biological function. Trends Neurosci. 20, 570-577.
32. Sadoshima, S., Nagao, T., Okada, Y., Fujii, K., Ibayashi, S., and Fujishima, M. (1997). l-Arginine ameliorates recir-culation and metabolic derangement in brain ischemia in hypertensive rats. Brain Res. 744, 246-252.
33. Satoh, T., and Lipton, S. A. (2007). Redox regulation of neuronal survival mediated by electrophilic compounds. Trends Neurosci. 30, 37-45.
34. Smriga, M., Ando, T., Akutsu, M., Furukawa, Y., Miwa, K., and Morinaga, Y. (2007). Oral treatment with l-lysine and l-arginine reduces anxiety and basal cortisol levels in healthy humans. Biomed. Res. 28, 85-90.
35. Smriga, M., Ghosh, S., Mouneimne, Y., Pellett, P. L., and Scrimshaw, N. S. (2004). Lysine fortifcation reduces anxiety and lessens stress in family members in economically weak communities in Northwest Syria. Proc. Natl. Acad. Sci. USA 101, 8285-8288.
36. Smriga, M., and Torii, K. (2003a). l-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats. Proc. Natl. Acad. Sci. USA 100, 15370-15375.
37. Smriga, M., and Torii, K. (2003b). Prolonged treatment with l-lysine and l-arginine reduces stress-induced anxiety in an elevated plus maze. Nutr. Neurosci. 6, 125-128.
38. Smulders, R. A., Aarsen, M., Teerlink, T., de Vries, P. M., van Kamp, G. J., Donker, A. J., and Stehouwer, C. D. (1997). Haemodynamic and biochemical responses to l-arginine and l-lysine infusions in normal subjects: l-ar-ginine induced vasodilation causes to be explained by non-specifc effects of cationic amino acids. Clin. Sci. (Colch) 92, 367-374.
39. Tamura, R., Kondoh, T., Ono, T., Nishijo, H., and Torii, K. (2000). Effects of repeated cold stress on activity of hypothalamic neurons in rats during performance of operant licking task. J. Neurophysiol. 84, 2844-2858.
40. Torii, K., Mimura, T., and Yugari, Y. (1987). "Biochemical mechanism of umami taste perception and effect of dietary protein on the taste preference for amino acids and sodium chloride in rats," in Umami: A Basic Taste, eds Y. Kawamura and M. R. Kare (New York: Marcel Dekker), 513-563.
41. Torii, K., Uneyama, H., Nishino, H., and Kondoh, T. (2004). Melatonin suppresses cerebral edema caused by middle cerebral artery occlusion/reperfusion in rats assessed by magnetic resonance imaging. J. Pineal Res. 36, 18-24.
42. Toung, T. J. K., Hurn, P. D., Traystman, R. J., and Bhardwaj, A. (2002). Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline. Crit. Care Med. 30, 644-649.
43. Wellendorph, P., Hansen, K. B., Balsgaard, A., Greenwood, J. R., Egebjerg, J., and Bräuner-Osborne, H. (2005). Deorphanization of GPRC6A: a promiscuous l-alpha-amino acid receptor with preference for basic amino acids. Mol. Pharmacol. 67, 589-597.
44. White, H. S., Chow, S. Y., Yen-Chow, Y. C., and Woodbury, D. M. (1992). Effect of elevated potassium on the ion content of mouse astrocytes and neurons. Can. J. Physiol. Pharmacol. 70 (Suppl), S263-S268.
45. Won, S. J., Kim, D. Y., and Gwag, B. J. (2002). Cellular and molecular pathways of ischemic neuronal death. J. Biochem. Mol. Biol. 35, 67-86.
46. Yamori, Y., Horie, R., Nara, Y., Ohtake, M., and Ikeda, K. (1977). Prophylactic trials for stroke in stroke-prone SHR (2). Effects of fat, protein and amino acids. Jpn. Heart J. 18, 551-553.
47. Yamori, Y., Horie, R., Ohtaka, M., Nara, Y., and Ikeda, K. (1978). Prophylactic trials for stroke in stroke-prone SHR. (3) Amino acid analysis of various diets and their prophylactic effect. Jpn. Heart J. 19, 624-626.
48. Young, V. R., and Pellett, P. L. (1990). Current concepts concerning indispensable amino acid needs in adults and their implications for international nutrition planning. Food Nutr. Bull. 12, 289-300.
49. Zhao, X., Ross, M. E., and Iadecola, C. (2003). l-Arginine increases ischemic injury in wild type mice but not in iNOS-defcient mice. Brain Res. 966, 308-311.
50. Zarei, M. M., and Dani, J. A. (1994). Ionic permeability characteristics of the N-methyl-d-aspartate receptor channel. J. Gen. Physiol. 103, 231-248.
51. Zhang, F., and Iadecola, C. (1994). Reduction of cerebral ischemic damage by delayed treatment with nitric oxide donors. J. Cereb. Blood Flow Metab. 14, 574-580.